KZR•benzinga•
Kezar Life Sciences Received A Letter From The Listing Qualifications Staff Of The Nasdaq Notifying The Company That It Has Regained Compliance With Nasdaq Listing Rule 5550(A)(2)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 14, 2024 by benzinga